Comparison of the Usefulness of Three Staging Systems for Hepatocellular Carcinoma (CLIP, BCLC, and JIS) in Japan

Toyoda, Hidenori; Kumada, Takashi; Kiriyama, Seiki; Sone, Yasuhiro; Tanikawa, Makoto; Hisanaga, Yasuhiro; Yamaguchi, Akihiro; Isogai, Masatoshi; Kaneoka, Yuji; Washizu, Junji
August 2005
American Journal of Gastroenterology;Aug2005, Vol. 100 Issue 8, p1764
Academic Journal
OBJECTIVES: We retrospectively compared the usefulness of three different staging systems for hepatocellular carcinoma (HCC), the Cancer of the Liver Italian Program (CLIP) scoring system, the Barcelona Clinic Liver Cancer (BCLC) classification system, and the Japan Integrated Staging (JIS) system, in terms of patient distribution and survival rates. METHODS: Subjects were 1,508 patients diagnosed as having initial HCC during the period of 1976–2003. The disease was staged in all patients by means of the three staging systems, and the distribution of patients across stages and associated survival rates were compared between systems. In addition, comparisons were made on the basis of the time of diagnosis: 1976–1990 (n = 497) and 1991–2003 (n = 1,011). RESULTS: Patients were evenly distributed across stages within each staging system, and survival rates differed between stages except for BCLC C and D. During the period 1991–2003, when HCCs were smaller at diagnosis, JIS system is in particular yielded even distribution of patient across stages and marked differences in survival rates. CONCLUSIONS: Overall, the CLIP and the JIS scoring systems proved to be suitable for patients in Japan with HCC. The CLIP staging systems proved to be more suitable before 1991. In contrast, the JIS system was the most suitable after 1990, when early detection and early treatment of HCC became common. The JIS system is, therefore, the appropriate system in this era of early detection and treatment of HCC. (Am J Gastroenterol 2005;100:1764–1771)


Related Articles

  • Comparison of the outcomes between anatomical resection and limited resection for single hepatocellular carcinomas no larger than 5 cm in diameter: a single-center study. Yamazaki, Osamu; Matsuyama, Mitsuharu; Horii, Katsuhiko; Kanazawa, Akishige; Shimizu, Sadatoshi; Uenishi, Takahiro; Ogawa, Masao; Tamamori, Yutaka; Kawai, Shuichi; Nakazawa, Kazunori; Otani, Hiroshi; Murase, Junya; Mikami, Shinichi; Higaki, Ikko; Arimoto, Yuichi; Hanba, Hiroyuki // Journal of Hepato -- Biliary -- Pancreatic Sciences;May2010, Vol. 17 Issue 3, p349 

    Background/Purpose: Liver resection is a widely preferred treatment modality for hepatocellular carcinomas (HCCs). This study aimed to compare the survival impact of anatomical resection with that of limited resection, in patients with single HCCs no larger than 5 cm in diameter. Methods: A...

  • TREATMENT OF PRIMARY CARCINOMA OF THE LIVER WITH NITROGEN MUSTARD AND PREDNISOLONE. Plengvanit, Ukrist; Viranuvatti, Vikit // American Journal of Gastroenterology;Nov1964, Vol. 42 Issue 5, p521 

    Discusses the use of nitrogen mustard and prednisolone for the treatment of primary carcinoma of the liver. Description of the antipyretic action of nitrogen mustard; Analysis of the size and consistency of the liver after treatment; Information on the therapeutic mechanism of nitrogen mustard...

  • Which parameters are needed for targeting a multitined radiofrequency device—an approach to a simple algorithm. Stippel, Dirk L.; Bangard, Christopher; Prenzel, Klaus; Yavuzyasar, Selim; Fischer, Jürgen H.; Hölscher, Arnulf H. // Langenbeck's Archives of Surgery;Sep2009, Vol. 394 Issue 4, p671 

    The use of radiofrequency ablation (RFA) for treatment of liver malignancies is limited by the high rate of local recurrences. The aim of this experimental study was to evaluate parameters describing the reproducible target volume of a RFA procedure in order to facilitate better applicator...

  • Surgery of liver metastases from colorectal cancer: new promises. Penna, Christophe; Nordlinger, Bernard // British Medical Bulletin;Dec2002, Vol. 64 Issue 1, p127 

    For a long time, patients with liver metastases from colorectal cancer were considered to be incurable. Over the last 30 years, the benefits of surgical resection and systemic chemotherapy have been established. Actually, surgical resections are feasible with a very low mortality and a 5-year...

  • Refining the role of laparoscopy and laparoscopic ultrasound in the staging of presumed pancreatic head and ampullary tumours. Thomson, B. N. J.; Parks, R. W.; Redhead, D. N.; Welsh, F. K. S.; Madhavan, K. K.; Wigmore, S. J.; Garden, O. J. // British Journal of Cancer;1/30/2006, Vol. 94 Issue 2, p213 

    Laparoscopy and laparoscopic ultrasound have been validated previously as staging tools for pancreatic cancer. The aim of this study was to identify if assessment of vascular involvement with abdominal computed tomography (CT) would allow refinement of the selection criteria for laparoscopy and...


    We present the case of a young woman, 22 years old, with an aggressive form of fibrolamellar hepatocellular carcinoma. She began with the signs and symptoms of a hyperammonemic encephalopathy, an uncommon form of presentation. Fibrolamellar carcinoma is a rare liver tumor, which affects young...

  • Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients. Zhou, Gang; Niu, Lizhi; Chiu, David; He, Lihua; Xu, Kecheng // Biotechnology Letters;Jul2012, Vol. 34 Issue 7, p1235 

    The presence of serum tumor markers, carbohydrate antigen 242 (CA242), carbohydrate antigen 199 (CA199), carbohydrate antigen 125 (CA125), carcinoembryonic antigen (CEA), tumor-supplied group of factors (TSGF) and tumor necrosis factor-α (TNF-α), is closely associated with invasion and...

  • Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy. Soomin Ahn; Jiyeon Hyeon; Cheol-Keun Park // Gut & Liver;Mar2013, Vol. 7 Issue 2, p206 

    Background/Aims: The prognosis after surgical resection of hepatocellular carcinoma (HCC) remains poor because of a high rate of recurrence. Thus, it is crucial to identify patients with a high risk of recurrence after curative hepatectomy and to develop more effective and targeted treatment...

  • Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom. Palmer, D H; Hussain, S A; Smith, A J; Hargreaves, S; Ma, Y T; Hull, D; Johnson, P J; Ross, P J // British Journal of Cancer;8/20/2013, Vol. 109 Issue 4, p888 

    Background:The prognosis for hepatocellular carcinoma (HCC) is dependent upon tumour stage, performance status (PS), severity of underlying liver disease, and the availability of appropriate therapies. The unavailability of sorafenib may have a significantly adverse effect on the prognosis of UK...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics